| 变量 | 总量(n = 321) | 未早期复发 (n = 209) | 早期复发 (n = 112) | Z/χ2值 | P值 |
| 术中出血mL，M(Q1, Q3) | 150.00 (100.00, 300.00) | 100.00 (100.00, 200.00) | 200.00 (100.00, 425.00) | Z = −2.65 | <0.01 |
| 间接胆红μmol/L，M(Q1, Q3) | 11.80 (9.00, 15.46) | 11.90 (9.22, 15.40) | 11.78 (8.38, 15.66) | Z = −0.87 | 0.38 |
| Child-pugh肝功能分级，n (%) |
|
|
| χ2 = 0.00 | 1.00 |
| A | 313 (97.51) | 204 (97.61) | 109 (97.32) |
|
|
| B | 8 (2.49) | 5 (2.39) | 3 (2.68) |
|
|
| 是否复发，n (%) |
|
|
| χ2 = 321.00 | <0.01 |
| 否 | 209 (65.11) | 209 (100.00) | 0 (0.00) |
|
|
| 是 | 112 (34.89) | 0 (0.00) | 112 (100.00) |
|
|
| 性别，n (%) |
|
|
| χ2 = 4.59 | 0.03 |
| 女 | 54 (16.82) | 42 (20.10) | 12 (10.71) |
|
|
| 男 | 267 (83.18) | 167 (79.90) | 100 (89.29) |
|
|
| 年龄 > 50岁，n (%) |
|
|
| χ2 = 0.32 | 0.57 |
| 否 | 80 (24.92) | 50 (23.92) | 30 (26.79) |
|
|
| 是 | 241 (75.08) | 159 (76.08) | 82 (73.21) |
|
|
| 甲胎蛋白 > 1000 ng/mL，n (%) |
|
|
| χ2 = 1.59 | 0.21 |
| 否 | 264 (82.24) | 176 (84.21) | 88 (78.57) |
|
|
| 是 | 57 (17.76) | 33 (15.79) | 24 (21.43) |
|
|
| 单细胞百分比 > 3%，n (%) |
|
|
| χ2 = 1.00 | 0.32 |
| 否 | 269 (83.80) | 172 (82.30) | 97 (86.61) |
|
|
| 是 | 52 (16.20) | 37 (17.70) | 15 (13.39) |
|
|
| 单细胞计数 > 0.1 × 109/L，n (%) |
|
|
| χ2 = 4.33 | 0.04 |
| 否 | 283 (88.16) | 190 (90.91) | 93 (83.04) |
|
|
| 是 | 38 (11.84) | 19 (9.09) | 19 (16.96) |
|
|
| 淋巴细胞百分比 > 20%，n (%) |
|
|
| χ2 = 4.71 | 0.03 |
| 否 | 28 (8.72) | 13 (6.22) | 15 (13.39) |
|
|
| 是 | 293 (91.28) | 196 (93.78) | 97 (86.61) |
|
|
| 淋巴细胞计数 > 0.8 × 109 L，n (%) |
|
|
| χ2 = 0.15 | 0.70 |
| 否 | 51 (15.89) | 32 (15.31) | 19 (16.96) |
|
|
| 是 | 270 (84.11) | 177 (84.69) | 93 (83.04) |
|
|
| 嗜碱性粒细胞百分比 > 1%，n (%) |
|
|
| χ2 = 0.22 | 0.64 |
| 否 | 298 (92.83) | 193 (92.34) | 105 (93.75) |
|
|
| 是 | 23 (7.17) | 16 (7.66) | 7 (6.25) |
|
|
| 嗜碱性粒细胞计数 > 0.8 × 109/L，n (%) |
|
|
| χ2 = 0.05 | 0.83 |
| 否 | 307 (95.64) | 199 (95.22) | 108 (96.43) |
|
|
| 是 | 14 (4.36) | 10 (4.78) | 4 (3.57) |
|
|
| 嗜酸性粒细胞百分比 > 0.5%，n (%) |
|
|
| χ2 = 0.18 | 0.67 |
| 否 | 15 (4.67) | 9 (4.31) | 6 (5.36) |
|
|
| 是 | 306 (95.33) | 200 (95.69) | 106 (94.64) |
|
|
| 嗜酸性粒细胞计数 > 50 × 106/L，n (%) |
|
|
| χ2 = 0.28 | 0.59 |
| 否 | 8 (2.49) | 4 (1.91) | 4 (3.57) |
|
|
| 是 | 313 (97.51) | 205 (98.09) | 108 (96.43) |
|
|
| 中性粒细胞百分比 > 42%，n (%) |
|
|
| χ2 = 0.00 | 0.97 |
| 否 | 17 (5.30) | 11 (5.26) | 6 (5.36) |
|
|
| 是 | 304 (94.70) | 198 (94.74) | 106 (94.64) |
|
|
| 中性粒细胞计数 > 2 × 109/L，n (%) |
|
|
| χ2 = 8.41 | <0.01 |
| 否 | 37 (11.53) | 32 (15.31) | 5 (4.46) |
|
|
| 是 | 284 (88.47) | 177 (84.69) | 107 (95.54) |
|
|
| 乙肝感染，n (%) |
|
|
| χ2 = 4.52 | 0.03 |
| 否 | 33 (10.28) | 27 (12.92) | 6 (5.36) |
|
|
| 是 | 288 (89.72) | 182 (87.08) | 106 (94.64) |
|
|
| 乙肝病毒DNA > 1000 IU/mL，n (%) |
|
|
| χ2 = 6.54 | 0.01 |
| 否 | 213 (66.36) | 149 (71.29) | 64 (57.14) |
|
|
| 是 | 108 (33.64) | 60 (28.71) | 48 (42.86) |
|
|
| 乙肝表面抗原，n (%) |
|
|
| χ2 = 4.89 | 0.03 |
| 阴性 | 41 (12.77) | 33 (15.79) | 8 (7.14) |
|
|
| 阳性 | 280 (87.23) | 176 (84.21) | 104 (92.86) |
|
|
| 乙肝前S1抗原，n (%) |
|
|
| χ2 = 6.03 | 0.01 |
| 阴性 | 54 (16.82) | 43 (20.57) | 11 (9.82) |
|
|
| 阳性 | 267 (83.18) | 166 (79.43) | 101 (90.18) |
|
|
| 乙肝e抗原，n (%) |
|
|
| χ2 = 1.99 | 0.16 |
| 阴性 | 87 (27.10) | 62 (29.67) | 25 (22.32) |
|
|
| 阳性 | 234 (72.90) | 147 (70.33) | 87 (77.68) |
|
|
| 谷氨酰基转移酶 > 32 U/L，n (%) |
|
|
| χ2 = 13.69 | <0.01 |
| 否 | 235 (73.21) | 167 (79.90) | 68 (60.71) |
|
|
| 是 | 86 (26.79) | 42 (20.10) | 44 (39.29) |
|
|
| 肿瘤分化，n (%) |
|
|
| χ2 = 5.69 | 0.02 |
| 高分化 | 192 (59.81) | 135 (64.59) | 57 (50.89) |
|
|
| 中低分化 | 129 (40.19) | 74 (35.41) | 55 (49.11) |
|
|
| 肿瘤最大直径 > 5 cm，n (%) |
|
|
| χ2 = 9.52 | <0.01 |
| 否 | 216 (67.29) | 153 (73.21) | 63 (56.25) |
|
|
| 是 | 105 (32.71) | 56 (26.79) | 49 (43.75) |
|
|
| 肿瘤数量 > 1，n (%) |
|
|
| χ2 = 7.22 | <0.01 |
| 否 | 300 (93.46) | 201 (96.17) | 99 (88.39) |
|
|
| 是 | 21 (6.54) | 8 (3.83) | 13 (11.61) |
|
|
| 被膜侵犯，n (%) |
|
|
| χ2 = 7.76 | <0.01 |
| 否 | 180 (56.07) | 129 (61.72) | 51 (45.54) |
|
|
| 是 | 141 (43.93) | 80 (38.28) | 61 (54.46) |
|
|
| 微血管侵犯，n (%) |
|
|
| χ2 = 24.03 | <0.01 |
| 否 | 166 (51.71) | 129 (61.72) | 37 (33.04) |
|
|
| 是 | 155 (48.29) | 80 (38.28) | 75 (66.96) |
|
|
| 卫星结节，n (%) |
|
|
| χ2 = 12.91 | <0.01 |
| 否 | 279 (86.92) | 192 (91.87) | 87 (77.68) |
|
|
| 是 | 42 (13.08) | 17 (8.13) | 25 (22.32) |
|
|
| 肝硬化，n (%) |
|
|
| χ2 = 3.32 | 0.07 |
| 否 | 119 (37.07) | 85 (40.67) | 34 (30.36) |
|
|
| 是 | 202 (62.93) | 124 (59.33) | 78 (69.64) |
|
|
| 抗病毒治疗，n (%) |
|
|
| χ2 = 1.18 | 0.28 |
| 否 | 59 (18.38) | 42 (20.10) | 17 (15.18) |
|
|
| 是 | 262 (81.62) | 167 (79.90) | 95 (84.82) |
|
|
| 术后预防性介入，n (%) |
|
|
| χ2 = 40.34 | <0.01 |
| 否 | 257 (80.06) | 189 (90.43) | 68 (60.71) |
|
|
| 是 | 64 (19.94) | 20 (9.57) | 44 (39.29) |
|
|
| BCLC分期，n (%) |
|
|
| χ2 = 10.87 | <0.01 |
| 0 | 54 (16.82) | 42 (20.10) | 12 (10.71) |
|
|
| A | 256 (79.75) | 164 (78.47) | 92 (82.14) |
|
|
| B | 11 (3.43) | 3 (1.44) | 8 (7.14) |
|
|
| CNLC分期，n (%) |
|
|
| χ2 = 5.56 | 0.02 |
| Ia + Ib | 310 (96.57) | 206 (98.56) | 104 (92.86) |
|
|
| II + III | 11 (3.43) | 3 (1.44) | 8 (7.14) |
|
|
| TNM分期，n (%) |
|
|
| χ2 = 7.22 | <0.01 |
| T1 | 300 (93.46) | 201 (96.17) | 99 (88.39) |
|
|
| T2 | 21 (6.54) | 8 (3.83) | 13 (11.61) |
|
|